Perspectum
Oxford, OX4 2LL, United Kingdom
Location status: Recruiting
Location contact
Haemdall Study Inbox Study Inbox
CONTACT
Mahd Siddiqi
PRINCIPAL_INVESTIGATOR
Susannah Krzyzanowski
CONTACT
NCT Number: NCT07098650
Haemdall: Using Medical Imaging to measure Brain Iron in Superficial Siderosis.
This study is looking at a new way of using MRI scans to potentially measure the amount of iron on the surface of the brain. Iron build up in the brain is linked to how superficial siderosis develops. The study will also aim to see if there is a connection between the amount of iron in the brain and common superficial siderosis symptoms. Clinical tests will be used to measure symptoms including tests to measure your hearing, walking & balance and participants' ability to remember, think and understand.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Oxford, OX4 2LL, United Kingdom
Location status: Recruiting
Haemdall Study Inbox Study Inbox
CONTACT
Mahd Siddiqi
PRINCIPAL_INVESTIGATOR
Susannah Krzyzanowski
CONTACT
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Superficial siderosis cohort:
Healthy cohort:
Exclusion criteria
Time frame: through study completion, an average of 1 year
Time frame: through study completion, an average of 1 year
Perspectum
Industry
Haemdall: Developing a Quantitative MRI Biomarker of Classical (Infratentorial) Superficial Siderosis of the Central Nervous System
Acronym: Haemdall
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04890808
Nervous System Diseases, Neurodegenerative Diseases
View Trial DetailsNCT01284127
Superficial Siderosis
Baltimore, Maryland, United States
View Trial Details